Adenoviruses as vaccine vectors

Tatsis, Nia; Ertl, Hildegund C.J.

doi:10.1016/j.ymthe.2004.07.013

Cited by 669Virus-based gene therapy researchImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 Research

Adenoviruses as vaccine vectors

Open access

Tatsis, Nia, Ertl, Hildegund C.J.·2004·Molecular Therapy

DOI 10.1016/j.ymthe.2004.07.013PMC PMC7106330

Open this paper in CoChat — free account

Abstract

Adenoviruses have transitioned from tools for gene replacement therapy to bona fide vaccine delivery vehicles. They are attractive vaccine vectors as they induce both innate and adaptive immune responses in mammalian hosts. Currently, adenovirus vectors are being tested as subunit vaccine systems for numerous infectious agents ranging from malaria to HIV-1. Additionally, they are being explored as vaccines against a multitude of tumor-associated antigens. In this review we describe the molecular biology of adenoviruses as well as ways the adenovirus vectors can be manipulated to enhance their efficacy as vaccine carriers. We describe methods of evaluating immune responses to transgene products expressed by adenoviral vectors and discuss data on adenoviral vaccines to a selected number of pathogens. Last, we comment on the limitations of using human adenoviral vectors and provide alternatives to circumvent these problems. This field is growing at an exciting and rapid pace, thus we have limited our scope to the use of adenoviral vectors as vaccines against viral pathogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2004.07.013

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Two immunisations produce a durable and long-lasting immune response.
“Furthermore, the use of two immunisations gives a durable and long-lasting immune response.8, 9”
From Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia (2021) · cites this paper as [8]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793 · see citing works
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574 · see citing works
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1× · see citing works
“3 , are now available [61] [62] [63] [64] .”
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102 · see citing works
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589 · see citing works
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173 · see citing works
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033 · see citing works
Self-citation
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018 · see citing works
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793 · see citing works
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655 · see citing works
First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response
MacGregor, R. R., Boyer, J., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515613 · Cited by 640 · see citing works
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637 · see citing works
MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 612 · see citing works
Self-citation
Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex
Stracker, T. H., Carson, C. T., & Weitzman, M. D. (2002) · Nature · doi:10.1038/nature00863 · Cited by 522 · see citing works
New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses
Fallaux, F. J., Bout, A., van der Velde, I., van den Wollenberg, D. J. M., Hehir, K. M., Keegan, J., Auger, C., Cramer, S. J., van Ormondt, H., van der Eb, A. J., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1909 · Cited by 480 · see citing works
Packaging capacity and stability of human adenovirus type 5 vectors
Bett, A. J., Prevec, L., & Graham, F. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.5911-5921.1993 · Cited by 472 · see citing works
Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity
Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Béthune, M., Kostense, S., Penders, G., Helmus, N., Koudstaal, W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8263-8271.2003 · Cited by 467 · see citing works
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 464 · see citing works
Epitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R. R., Guest, S. B., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459 · see citing works
Detection of Antigen-Specific T Cells with Multivalent Soluble Class II MHC Covalent Peptide Complexes
Crawford, F., Kozono, H., White, J., Marrack, P., & Kappler, J. W. (1998) · Immunity · doi:10.1016/s1074-7613(00)80572-5 · Cited by 459 · see citing works
PEGylation of Adenovirus with Retention of Infectivity and Protection from Neutralizing Antibody in Vitro and in Vivo
O’Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., & Francis, G. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018021 · Cited by 409 · see citing works
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene
Casimiro, D. R., Chen, L., Fu, T., Evans, R. K., Caulfield, M. J., Davies, M.-E., Tang, A., Chen, M., Huang, L., Harris, V. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6305-6313.2003 · Cited by 399 · see citing works
Adenovirus virus-associated RNA and translation control
Mathews, M. B., & Shenk, T. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.5657-5662.1991 · Cited by 393 · see citing works
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
Barouch, D. H., Pau, M. G., Custers, J. H. H. V., Koudstaal, W., Kostense, S., Havenga, M. J. E., Truitt, D. M., Sumida, S. M., Kishko, M., Arthur, J. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6290 · Cited by 383 · see citing works
Acute Cytokine Response to Systemic Adenoviral Vectors in Mice Is Mediated by Dendritic Cells and Macrophages
Zhang, Y., Chirmule, N. B., Gao, G., Qian, R., Croyle, M. A., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 377 · see citing works
Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors
Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G., Yu, Q., Qian, R., Chen, S., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 343 · see citing works
The impact of adenovirus infection on the immunocompromised host
Kojaoghlanian, T., Flomenberg, P. R., & Horwitz, M. S. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.386 · Cited by 333 · see citing works
Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes
Garnett‐Benson, C., Erdman, D. D., Xu, W., & Gooding, L. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10608-10616.2002 · Cited by 328 · see citing works
In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted
Lusky, M., Christ, M., Rittner, K., Dieterlé, A., Dreyer, D., Mourot, B., Schultz, H., Stoeckel, F., Pavirani, A., & Mehtali, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2022-2032.1998 · Cited by 289 · see citing works
Crystal structure of reovirus attachment protein σ1 reveals evolutionary relationship to adenovirus fiber
Chappell, J. D., Prota, A. E., Dermody, T. S., & Stehle, T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.1 · Cited by 278 · see citing works
Effects of a SARS-associated coronavirus vaccine in monkeys
Gao, W., Tamin, A., Soloff, A. C., D’Aiuto, L., Nwanegbo, E. C., Robbins, P. D., Bellini, W. J., Barratt‐Boyes, S. M., & Gambotto, A. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14962-8 · Cited by 271 · see citing works
Replication-Defective Vector Based on a Chimpanzee Adenovirus
Farina, S. F., Gao, G., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J. A., Ertl, H. C. J., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11603-11613.2001 · Cited by 271 · see citing works
Self-citation
A Simple Method for Constructing E1- and E1/E4-Deleted Recombinant Adenoviral Vectors
Mizuguchi, H., & Kay, M. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950017374 · Cited by 261 · see citing works
A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier
Xiang, Z., Yang, Y., Wilson, J. M., & Ertl, H. C. J. (1996) · Virology · doi:10.1006/viro.1996.0239 · Cited by 241 · see citing works
Self-citation
HIV vaccines 1983–2003
McMichael, A. J., & Hanke, T. (2003) · Nature Medicine · doi:10.1038/nm0703-874 · Cited by 240 · see citing works
Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway
Morelli, A. E., Larregina, A. T., Ganster, R. W., Zahorchak, A. F., Plowey, J. M., Takayama, T., Logar, A., Robbins, P. D., Falo, L. D., & Thomson, A. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9617-9628.2000 · Cited by 222 · see citing works
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms
Wohlfart, C. (1988) · Journal of Virology · doi:10.1128/jvi.62.7.2321-2328.1988 · Cited by 218 · see citing works
A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag
Fitzgerald, J. C., Gao, G., Reyes‐Sandoval, A., Pavlakis, G. N., Xiang, Z., Wlazlo, A. P., Giles‐Davis, W., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1416 · Cited by 216 · see citing works
Self-citation
Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting
Yang, Z., Wyatt, L. S., Kong, W., Moodie, Z., Moss, B., & Nabel, G. J. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.799-803.2003 · Cited by 204 · see citing works
Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product
Xiang, Z., Gao, G., Reyes‐Sandoval, A., Cohen, C. J., Li, Y., Bergelson, J. M., Wilson, J. M., & Ertl, H. C. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2667-2675.2002 · Cited by 194 · see citing works
Self-citation
Protection against Mucosal Simian Immunodeficiency Virus SIV mac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting
Patterson, L. J., Malkevitch, N., Venzon, D. J., Pinczewski, J., Román, R. G., Wang, L., Kalyanaraman, V. S., Markham, P. D., Robey, F. A., & Robert-Guroff, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2212-2221.2004 · Cited by 172 · see citing works
Detection of individual mouse splenic T cells producing IFN-γ and IL-5 using the enzyme-linked immunospot (ELISPOT) assay
Taguchi, T., McGhee, J. R., Coffman, R. L., Beagley, K. W., Eldridge, J. H., Takatsu, K., & Kiyono, H. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90464-7 · Cited by 167 · see citing works
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors
Short, J. J., Pereboev, A. V., Kawakami, Y., Vasu, C., Holterman, M., & Curiel, D. T. (2004) · Virology · doi:10.1016/j.virol.2004.02.016 · Cited by 164 · see citing works
Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells
Réa, D., Havenga, M. J. E., van den Assem, M., Sutmuller, R. P. M., Lemckert, A. A. C., Hoeben, R. C., Bout, A., Melief, C. J. M., & Offringa, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5236 · Cited by 158 · see citing works
Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System
Lemiale, F., Kong, W., Akyürek, L. M., Xu, L., Huang, Y., Chakrabarti, B. K., Eckhaus, M., & Nabel, G. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.10078-10087.2003 · Cited by 158 · see citing works
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization
Lubeck, M. D., Natuk, R. J., Myagkikh, M., Kalyan, N. K., Aldrich, K., Sinangil, F., Alipanah, S., MURTHY, S. C. S., Chanda, P. K., Nigida, S. M., et al. (1997) · Nature Medicine · doi:10.1038/nm0697-651 · Cited by 152 · see citing works
Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus
Gallichan, W. S., & Rosenthal, K. L. (1995) · Vaccine · doi:10.1016/0264-410x(95)00100-f · Cited by 150 · see citing works
Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome
Saito, I., Oya, Y., Yamamoto, K., Yuasa, T., & Shimojo, H. (1985) · Journal of Virology · doi:10.1128/jvi.54.3.711-719.1985 · Cited by 147 · see citing works
A Recombinant Human Adenovirus Vaccine against Rabies
PREVEC, L., Campbell, J. B., Christie, B. S., Belbeck, L. W., & Graham, F. L. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.1.27 · Cited by 147 · see citing works
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.
Lubeck, M. D., Davis, A. R., Chengalvala, M., Natuk, R. J., Morin, J. E., Molnar-Kimber, K. L., Mason, B. B., Bhat, B. M., Mizutani, S., & Hung, P. P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6763 · Cited by 147 · see citing works
Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSV
Connors, M., Collins, P. L., Firestone, C.-Y., Sotnikov, A. V., Waitze, A., Davis, A. R., Hung, P. P., Chanock, R. M., & Murphy, B. R. (1992) · Vaccine · doi:10.1016/0264-410x(92)90397-3 · Cited by 145 · see citing works
Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
Xiang, Z., Gao, G., Reyes‐Sandoval, A., Li, Y., Wilson, J. M., & Ertl, H. C. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.10780-10789.2003 · Cited by 140 · see citing works
Self-citation
Long‐Term Immunity and Protection against Herpes Simplex Virus Type 2 in the Murine Female Genital Tract after Mucosal but Not Systemic Immunization
Gallichan, W. S., & Rosenthal, K. L. (1998) · The Journal of Infectious Diseases · doi:10.1086/515286 · Cited by 133 · see citing works
Group C adenovirus DNA sequences in human lymphoid cells
Horváth, J. K., Palkonyay, L., & WEBER, J. M. (1986) · Journal of Virology · doi:10.1128/jvi.59.1.189-192.1986 · Cited by 131 · see citing works
Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit
Yeh, P., Dedieu, J.-F., Orsini, C., Vigne, E., Denèfle, P., & Perricaudet, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.559-565.1996 · Cited by 125 · see citing works
Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-α induction pathway
Philpott, N. J., Nociari, M., Elkon, K. B., & Falck-Pedersen, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308368101 · Cited by 118 · see citing works
Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene
Haj-Ahmad, Y., & Graham, F. L. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.267-274.1986 · Cited by 115 · see citing works
The Adenovirus Capsid Protein Hexon Contains a Highly Conserved Human CD4 + T-Cell Epitope
Olive, M., Eisenlohr, L. C., Flomenberg, N., Hsu, S. H., & Flomenberg, P. R. (2002) · Human Gene Therapy · doi:10.1089/104303402320138952 · Cited by 114 · see citing works
Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers
Pinto, A. R., Fitzgerald, J. C., Giles‐Davis, W., Gao, G. P., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6774 · Cited by 113 · see citing works
Self-citation
Control of adenovirus acute respiratory disease in U.S. Army trainees.
Fh, T. (1975) · PubMed · Cited by 111 · see citing works
Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response
Sailaja, G. S., HogenEsch, H., North, A., Hays, J., & Mittal, S. K. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301858 · Cited by 111 · see citing works
Viral Recombinant Vaccines to the E6 and E7 Antigens of HPV-16
He, Z., Wlazlo, A. P., Kowalczyk, D. W., Cheng, J., Xiang, Z., Giles‐Davis, W., & Ertl, H. C. J. (2000) · Virology · doi:10.1006/viro.2000.0271 · Cited by 109 · see citing works
Self-citation
Ovine Adenovirus Vectors Overcome Preexisting Humoral Immunity against Human Adenoviruses In Vivo
Hofmann, C., Löser, P., Cichon, G., Arnold, W., Both, G. W., & Strauss, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6930-6936.1999 · Cited by 108 · see citing works
Genome Type Analysis of Adenovirus Types 3 and 7 Isolated during Successive Outbreaks of Lower Respiratory Tract Infections in Children
Kim, Y., Hong, J.-Y., Lee, H. J., Shin, S.-H., Kim, Y. K., Inada, T., Hashido, M., & Piedra, P. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4594-4599.2003 · Cited by 102 · see citing works
Contaminated polio vaccine theory refuted
Worobey, M., Santiago, M. L., Keele, B. F., Ndjango, J.-B. N., Joy, J. B., Labama, B. L., Dhed’a, B. D., Rambaut, A., Sharp, P. M., Shaw, G. M., et al. (2004) · Nature · doi:10.1038/428820a · Cited by 100 · see citing works
Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector
Sakurai, F., Mizuguchi, H., Yamaguchi, T., & Hayakawa, T. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00243-0 · Cited by 100 · see citing works
Requirement of the Adenovirus IVa2 Protein for Virus Assembly
Zhang, W., & Imperiale, M. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.6.3586-3594.2003 · Cited by 97 · see citing works
Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted
Zhou, H., O’Neal, W. K., Morral, N., & Beaudet, A. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7030-7038.1996 · Cited by 95 · see citing works
Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes
Reyes‐Sandoval, A., Fitzgerald, J. C., Grant, R., Roy, S., Xiang, Z., Li, Y., Gao, G., Wilson, J. M., & Ertl, H. C. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7392-7399.2004 · Cited by 91 · see citing works
Self-citation
Identification of Adenovirus (Ad) Penton Base Neutralizing Epitopes by Use of Sera from Patients Who Had Received Conditionally Replicative Ad (Ad dl 1520) for Treatment of Liver Tumors
Hong, S. S., Habib, N. A., Franqueville, L., Jensen, S., & Boulanger, P. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10366-10375.2003 · Cited by 90 · see citing works
Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant Adenovirus
Youil, R., Toner, T. J., Su, Q., Chen, M., Tang, A., Bett, A. J., & Casimiro, D. R. (2002) · Human Gene Therapy · doi:10.1089/10430340252769824 · Cited by 87 · see citing works
Replication-defective recombinant adenovirus expressing the Epstein--Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin
Ragot, T., Finerty, S., Watkins, P. E., Perricaudet, M., & Morgan, A. J. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-3-501 · Cited by 87 · see citing works
Enhanced Gene Transfer to Mouse Dendritic Cells Using Adenoviral Vectors Coated with a Novel Adapter Molecule
Pereboev, A. V., Nagle, J. M., Shakhmatov, M. A., Triozzi, P. L., Matthews, Q. L., Kawakami, Y., Curiel, D. T., & Blackwell, J. L. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.006 · Cited by 86 · see citing works
Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene
Casimiro, D. R., Tang, A., Chen, L., Fu, T., Evans, R. K., Davies, M.-E., Freed, D. C., Hurni, W. M., Aste-Amézaga, J. M., Guan, L., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7663-7668.2003 · Cited by 85 · see citing works
Generation of an Adenovirus Vector Lacking E1, E2a, E3, and All of E4 except Open Reading Frame 3
Gorziglia, M. I., Lapcevich, C., Roy, S., Kang, A., Kadan, M., Wu, V., Pechan, P. A., & Kaleko, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6048-6055.1999 · Cited by 83 · see citing works
Immune Effector Mechanisms Required for Protection to Rabies Virus
Xiang, Z., Knowles, B. B., McCarrick, J. W., & Ertl, H. C. J. (1995) · Virology · doi:10.1006/viro.1995.0049 · Cited by 81 · see citing works
Self-citation
Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine
Duraiswamy, J., Bharadwaj, M., Tellam, J., Connolly, G., Cooper, L. T., Moss, D. J., Thomson, S., Yotnda, P., & Khanna, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2196 · Cited by 81 · see citing works
Human adenovirus type 35: nucleotide sequence and vector development
Gao, W., Robbins, P. D., & Gambotto, A. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302097 · Cited by 80 · see citing works
A chimeric adenovirus vector encoding reovirus attachment protein σ1 targets cells expressing junctional adhesion molecule 1
Mercier, G. T., Campbell, J. A., Chappell, J. D., Stehle, T., Dermody, T. S., & Barry, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400542101 · Cited by 80 · see citing works
Modification to the Capsid of the Adenovirus Vector That Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses
Worgall, S., Busch, A., Rivara, M., Bonnyay, D., Leopold, P. L., Merritt, R. E., Hackett, N. R., Rovelink, P. W., Bruder, J. T., Wickham, T. J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2572-2580.2004 · Cited by 78 · see citing works
High-Level Expression of the Measles Virus Nucleocapsid Protein by Using a Replication-Deficient Adenovirus Vector: Induction of an MHC-1-Restricted CTL Response and Protection in a Murine Model
Fooks, A. R., Schadeck, E. B., Liebert, U. G., Dowsett, A. B., RIMA, B. K., Steward, M. W., Stephenson, J. R., & Wilkinson, G. W. G. (1995) · Virology · doi:10.1006/viro.1995.1362 · Cited by 77 · see citing works
Human adenovirus cloning vectors based on infectious bacterial plasmids
Ghosh-Choudhury, G., Haj-Ahmad, Y., Brinkley, P., Rudy, J., & Graham, F. L. (1986) · Gene · doi:10.1016/0378-1119(86)90321-5 · Cited by 76 · see citing works
Induction of CD8 T Cells by Vaccination with Recombinant Adenovirus Expressing Human Papillomavirus Type 16 E5 Gene Reduces Tumor Growth
Liu, D., Tsao, Y., Hsieh, C., Hsieh, J., Kung, J. T., Chiang, C.-L., Huang, S.-J., & Chen, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9083-9089.2000 · Cited by 71 · see citing works
Rabies Update for Travel Medicine Advisors
Wilde, H., Briggs, D. J., Meslin, F.-X., Hemachudha, T., & Sitprija, V. (2003) · Clinical Infectious Diseases · doi:10.1086/375605 · Cited by 70 · see citing works
Immunogenicity of Recombinant Adenovirus-Respiratory Syncytial Virus Vaccines with Adenovirus Types 4, 5, and 7 Vectors in Dogs and a Chimpanzee
Hsu, K.-H. L., Lubeck, M. D., Davis, A. R., Bhat, R. A., Selling, B. H., Bhat, B. M., Mizutani, S., Murphy, B. R., Collins, P. L., Chanock, R. M., et al. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.4.769 · Cited by 69 · see citing works
Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor
Cohen, C. J., Xiang, Z., Gao, G., Ertl, H. C. J., Wilson, J. M., & Bergelson, J. M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-1-151 · Cited by 67 · see citing works
Self-citation
Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2
Jaiswal, S., Khanna, N., & Swaminathan, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12907-12913.2003 · Cited by 65 · see citing works
Protective Immunity to Rotavirus-Induced Diarrhoea Is Passively Transferred to Newborn Mice from Naive Dams Vaccinated with a Single Dose of a Recombinant Adenovirus Expressing Rotavirus VP7sc
Both, G. W., Lockett, L. J., Janardhana, V., Edwards, S. J., Bellamy, A. R., Graham, F. L., PREVEC, L., & Andrew, M. E. (1993) · Virology · doi:10.1006/viro.1993.1203 · Cited by 64 · see citing works
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
Arribillaga, L., de Cerio, A. L. D., Sarobe, P., Casares, N., Gorraiz, M., Vales, Á., Bruña–Romero, O., Borrás‐Cuesta, F., Paranhos‐Baccalà, G., Prìeto, J., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00456-5 · Cited by 61 · see citing works
Induction of Genital Immunity by DNA Priming and Intranasal Booster Immunization with a Replication-Defective Adenoviral Recombinant
Xiang, Z., Pasquini, S., & Ertl, H. C. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6716 · Cited by 60 · see citing works
Self-citation
Intracranial Administration of Adenovirus Expressing HSV-TK in Combination with Ganciclovir Produces a Dose-Dependent, Self-Limiting Inflammatory Response
Smith, J. G., Raper, S. E., Wheeldon, E. B., Hackney, D. B., Judy, K. D., Wilson, J. M., & Eck, S. L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.8-943 · Cited by 59 · see citing works
Fatal Disseminated Adenovirus Infections in Immunocompromised Patients
Pham, T. T. N., Burchette, J. L., & Hale, L. P. (2003) · American Journal of Clinical Pathology · doi:10.1309/awxdgnc5d70en7yt · Cited by 59 · see citing works
The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain
Molinier‐Frenkel, V., Prévost‐Blondel, A., Hong, S. S., Lengagne, R., Boudaly, S., Magnusson, M. K., Boulanger, P. A., & Guillet, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303496200 · Cited by 56 · see citing works
Fatal Disseminated Adenovirus Infections in Immunocompromised Patients
Pham, T. T. N., Burchette, J. L., & Hale, L. P. (2003) · American Journal of Clinical Pathology · doi:10.1309/awxd-gnc5-d70e-n7yt · Cited by 55 · see citing works
Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid
Matsui, M., Moriya, O., & Akatsuka, T. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00704-1 · Cited by 52 · see citing works
High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system
Alkhatib, G., & Briedis, D. J. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2718-2727.1988 · Cited by 51 · see citing works
Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques
Tobery, T. W., Smith, J. F., Kuklin, N. A., Skulsky, D., Ackerson, C., Huang, L., Chen, L., Cook, J. C., McClements, W. L., & Jansen, K. U. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00679-5 · Cited by 48 · see citing works
Improved Protection of Rhesus Macaques against Intrarectal Simian Immunodeficiency Virus SIVmac251Challenge by a Replication-Competent Ad5hr-SIVenv/revand Ad5hr-SIVgagRecombinant Priming/gp120 Boosting Regimen
Zhao, J., Pinczewski, J., Román, R. G., Venzon, D. J., Kalyanaraman, V. S., Markham, P. D., Aldrich, K., Moake, M. M., Montefiori, D. C., Lou, Y., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8354-8365.2003 · Cited by 48 · see citing works
Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime–adenovirus boost
Park, S., Yang, S.-H., Lee, C. G., Youn, J., Chang, J., & Sung, Y. C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00499-7 · Cited by 46 · see citing works
Construction of Adenoviral Vectors
Davis, A. R., Wivel, N. A., Palladino, J. L., Tao, L., & Wilson, J. M. (2001) · Molecular Biotechnology · doi:10.1385/mb:18:1:63 · Cited by 45 · see citing works
Single Oral Immunization with Replication Deficient Recombinant Adenovirus Elicits Long-Lived Transgene-Specific Cellular and Humoral Immune Responses
Sharpe, S. A., Fooks, A. R., Lee, J., Hayes, K., Clegg, C. S., & Cranage, M. P. (2002) · Virology · doi:10.1006/viro.2001.1281 · Cited by 44 · see citing works
Generation of Adenovirus Vectors Devoid of All Viral Genes by Recombination Between Inverted Repeats
Stecher, H., Carlson, C. A., Shayakhmetov, D. M., & Lieber, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-304-6:135 · Cited by 44 · see citing works
Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus
Makimura, M. (1996) · Vaccine · doi:10.1016/0264-410x(95)00161-s · Cited by 43 · see citing works
Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration
Vos, A. C., Neubert, A., Pommerening, E., Müller, T., Döhner, L., Neubert, L., & Hughes, K. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-9-2191 · Cited by 42 · see citing works
Generation of Adenovirus Vectors Devoid of All Viral Genes by Recombination between Inverted Repeats
Steinwaerder, D. S., Carlson, C. A., & Lieber, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9303-9313.1999 · Cited by 40 · see citing works
Activation of Adenoviral Gene Expression by Protein IX Is Not Required for Efficient Virus Replication
Sargent, K. L., Meulenbroek, R. A., & Parks, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5032-5037.2004 · Cited by 39 · see citing works
pAd5-Blue: Direct Ligation System for Engineering Recombinant Adenovirus Constructs
Moraes, M. P., Mayr, G. A., & Grubman, M. J. (2001) · BioTechniques · doi:10.2144/01315st05 · Cited by 38 · see citing works
Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector
Pinto, A. R., Fitzgerald, J. C., Gao, G., Wilson, J. M., & Ertl, H. C. J. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.029 · Cited by 38 · see citing works
Self-citation
The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus
Wang, Y., Xiang, Z., Pasquini, S., & Ertl, H. C. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3677-3683.1997 · Cited by 37 · see citing works
Self-citation
The Adenovirus E3 RID Complex Protects Some Cultured Human T and B Lymphocytes from Fas-Induced Apoptosis
McNees, A. L., Garnett‐Benson, C., & Gooding, L. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9716-9723.2002 · Cited by 36 · see citing works
Comparative Analysis of the Effects of Packaging Signal, Transgene Orientation, Promoters, Polyadenylation Signals, and E3 Region on Growth Properties of First-Generation Adenoviruses
Youil, R., Toner, T. J., Su, Q., Casimiro, D. R., Shiver, J. W., Chen, L., Bett, A. J., Rogers, B. M., Burden, E. C., Tang, A., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403766682278 · Cited by 34 · see citing works
Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice
Xiang, Z., Li, Y., Gao, G., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4287 · Cited by 33 · see citing works
Self-citation
Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.
Fooks, A. R., JEEVARAJAH, D., Lee, J., ter Meulen, V., Clegg, J. C. S., Warnes, A., Niewiesk, S., & Stephenson, J. R. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-5-1027 · Cited by 30 · see citing works
Induction of mucosal immunity with a replication-defective adenoviral recombinant
Xiang, Z. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00449-6 · Cited by 29 · see citing works
Improved permeabilization procedure for flow cytometric detection of internal antigens Analysis of interleukin-2 production
Labalette, M., Torpier, G., Capron, A., & Dessaint, J. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90162-9 · Cited by 28 · see citing works
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost
Vinner, L., Wee, E. G., Patel, S. P., Corbet, S., Gao, G. P., Nielsen, C., Wilson, J. M., Ertl, H. C. J., Hanke, T., & Fomsgaard, A. (2003) · Journal of General Virology · doi:10.1099/vir.0.18589-0 · Cited by 28 · see citing works
Self-citation
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity
Shanley, J. D., & Wu, C. A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00037-9 · Cited by 27 · see citing works
An efficient procedure to select and recover recombinant adenovirus vectors.
Jl, I., Chartier, C., Dieterle, A., Dreyer, D., Mehtali, M., & Pavirani, A. (1995) · PubMed · Cited by 27 · see citing works
Efficient Transduction of Human Monocyte-Derived Dendritic Cells by Chimpanzee-Derived Adenoviral Vector
Varnavski, A. N., Schlienger, K., Bergelson, J. M., Gao, G., & Wilson, J. M. (2003) · Human Gene Therapy · doi:10.1089/104303403764539323 · Cited by 26 · see citing works
Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice
Bruce, C., Akrigg, A., Sharpe, S. A., Hanke, T., Wilkinson, G. W. G., & Cranage, M. P. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-10-2621 · Cited by 26 · see citing works
Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7sc
Xu, Z. Z., Krougliak, V. A., PREVEC, L., Graham, F. L., & Both, G. W. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-8-1971 · Cited by 25 · see citing works
Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB
Berencsi, K., Rando, R. F., deTaisne, C., Paoletti, E., Plotkin, S. A., & Gönczöl, É. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2507 · Cited by 25 · see citing works
Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses
Seong, Y. R., Choi, S., Lim, J., Lee, C.-H., Lee, C.-K., & Im, D. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00534-x · Cited by 24 · see citing works
Merck Reemerges With a Bold AIDS Vaccine Effort
Cohen, J. D. (2001) · Science · doi:10.1126/science.292.5514.24 · Cited by 23 · see citing works
Serologic Classification of Chimpanzee Adenoviruses by Hemagglutination and Hemagglutination Inhibition
Hillis, W. D., & Goodman, R. (1969) · The Journal of Immunology · doi:10.4049/jimmunol.103.5.1089 · Cited by 23 · see citing works
Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols
Yoshida, T., Okuda, K., Xin, K.-Q., Tadokoro, K., Fukushima, J., Toda, S., Hagiwara, E., Hamajima, K., Koshino, T., & Saito, T. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01540.x · Cited by 21 · see citing works
Stability of a Recombinant Adenoviral Vector: Optimization of Conditions for Storage, Transport and Delivery
Ugai, H., Watanabe, S., Suzuki, É., Tsutsui, H., Yokoyama, K. K., & Murata, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01296.x · Cited by 17 · see citing works
Potent, Persistent Cellular Immune Responses Elicited by Sequential Immunization of Rhesus Macaques with Ad5 Host Range Mutant Recombinants Encoding SIV Rev and SIV Nef
Patterson, L. J., Malkevitch, N., Zhao, J., Peng, B., & Robert-Guroff, M. (2002) · DNA and Cell Biology · doi:10.1089/104454902760330165 · Cited by 15 · see citing works
Current use and future directions of adenovirus vaccine.
Gurwith, M., Gs, H., Impellizzeri, C. A., Davis, A. R., Lubeck, M. D., & Hung, P. P. (1989) · PubMed · Cited by 14 · see citing works
Electrophoretic Mobility Shift Scanning Using an Automated Infrared DNA Sequencer
Sano, M., Ohyama, A., Takase, K., Yamamoto, M., & Machida, M. (2001) · BioTechniques · doi:10.2144/01315st06 · Cited by 11 · see citing works
Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo
Mercier, S., Verhaagh, S., Goudsmit, J., Lemckert, A. A. C., Monteil, M., Havenga, M. J. E., & Éloit, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.79846-0 · Cited by 8 · see citing works
Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccines.
Hung, P. P., Chanda, P. K., Natuk, R. J., Mason, B. B., Chengalvala, M., Bhat, B. M., Molnar-Kimber, K. L., Dheer, S. K., Morin, J. E., & Mizutani, S. (1990) · PubMed · Cited by 6 · see citing works

Flagged first, then by citations

2 of the 134 references couldn’t be matched to a known paper.

Sorted by citations

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Logunov, D. Y., Dolzhikova, I. V., Shcheblyakov, D. V., Tukhvatulin, A. I., Zubkova, O. V., Dzharullaeva, A. S., Kovyrshina, A. V., Lubenets, N. L., Grousova, D. M., Erokhova, A. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00234-8 · Cited by 1,747 · see citing works
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., Luca, P. M. D., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P. L., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,364 · see citing works
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31866-3 · Cited by 1,055 · see citing works
Viral Vectors for Gene Therapy: Translational and Clinical Outlook.
Kotterman, M., Chalberg, T., & Schaffer, D. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104938 · Cited by 425 · see citing works
SARS-CoV-2 Vaccines
Creech, C. B., Walker, S. C., & Samuels, R. J. (2021) · JAMA · doi:10.1001/jama.2021.3199 · Cited by 420 · see citing works
Current state and challenges in developing oral vaccines
Ramirez, J. E. V., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 410 · see citing works
Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein Networks
Liu, H., Jin, L., Koh, S. B. S., Atanasov, I. C., Schein, S., Wu, L., & Zhou, Z. H. (2010) · Science · doi:10.1126/science.1187433 · Cited by 384 · see citing works
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Dicks, M. D. J., Spencer, A. J., Edwards, N. J., Wadell, G., Bojang, K., Gilbert, S. C., Hill, A. V. S., & Cottingham, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040385 · Cited by 384 · see citing works
Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent Pathways
Zhu, J., Huang, X., & Yang, Y. (2007) · Journal of Virology · doi:10.1128/jvi.02192-06 · Cited by 370 · see citing works
Recombinant vaccines and the development of new vaccine strategies
Nascimento, I. P., & Leite, L. C. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500142 · Cited by 367 · see citing works
Viruses as vaccine vectors for infectious diseases and cancer
Draper, S. J., & Heeney, J. L. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2240 · Cited by 352 · see citing works
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
Folgori, A., Capone, S., Ruggeri, L., Meola, A., Sporeno, E., Ercole, B. B., Pezzanera, M., Tafi, R., Arcuri, M., Fattori, E., et al. (2006) · Nature Medicine · doi:10.1038/nm1353 · Cited by 322 · see citing works
The use of viral vectors in vaccine development
Travieso, T., Li, J., Mahesh, S., Mello, J. D. F. R. E., & Blasi, M. (2022) · npj Vaccines · doi:10.1038/s41541-022-00503-y · Cited by 314 · see citing works
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Colloca, S., Barnes, E. J., Folgori, A., Ammendola, V., Capone, S., Cirillo, A., Siani, L., Naddeo, M., Grazioli, F., Esposito, M. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002925 · Cited by 299 · see citing works
Pre-existing immunity against Ad vectors
Fausther‐Bovendo, H., & Kobinger, G. P. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29594 · Cited by 277 · see citing works
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
Mast, T. C., Kierstead, L. S., Gupta, S. B., Nikas, A. A., Kallas, E. G., Novitsky, V., Mbewe, B., Pitisuttithum, P., Schechter, M., Vardas, E., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.145 · Cited by 276 · see citing works
Viral Delivery Systems for CRISPR
Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019) · Viruses · doi:10.3390/v11010028 · Cited by 277 · see citing works
Viral <scp>vector‐based</scp> gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269 · see citing works
New Insights on Adenovirus as Vaccine Vectors
Lasaro, M. O., & Ertl, H. C. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.130 · Cited by 263 · see citing works
Self-citation
Adenovirus Receptors
Zhang, Y., & Bergelson, J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12125-12131.2005 · Cited by 262 · see citing works
Modification of Adenovirus Gene Transfer Vectors With Synthetic Polymers: A Scientific Review and Technical Guide
Kreppel, F., & Kochanek, S. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300321 · Cited by 239 · see citing works
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
O’Hara, G. A., Duncan, C. J. A., Ewer, K., Collins, K. A., Elias, S. C., Halstead, F. D., Goodman, A. L., Edwards, N. J., Reyes‐Sandoval, A., Bird, P., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir850 · Cited by 214 · see citing works
Engineered lentivector targeting of dendritic cells for in vivo immunization
Yang, L., Yang, H., Rideout, K., Cho, T., Joo, K. I., Ziegler, L., Elliot, A. M., Walls, A., Yu, D., Baltimore, D., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1390 · Cited by 208 · see citing works
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research
Heppner, D. G., Kester, K. E., Ockenhouse, C. F., Tornieporth, N., Ofori, O., Lyon, J. A., Stewart, V. A., Dubois, P. M., Lanar, D. E., & Krzych, U. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.142 · Cited by 193 · see citing works
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
Lundstrom, K. H. (2023) · Viruses · doi:10.3390/v15030698 · Cited by 196 · see citing works
Replication-defective viruses as vaccines and vaccine vectors
Dudek, T., & Knipe, D. M. (2005) · Virology · doi:10.1016/j.virol.2005.09.020 · Cited by 189 · see citing works
Progress and Challenges toward the Development of Vaccines against Avian Infectious Bronchitis
Bande, F., Arshad, S. S., Bejo, M. H., Moeini, H., & Omar, A. R. (2015) · Journal of Immunology Research · doi:10.1155/2015/424860 · Cited by 167 · see citing works
Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass
Alcock, R. S., Cottingham, M. G., Rollier, C. S., Furze, J. M., Costa, S. D. D., Hanlon, M., Spencer, A. J., Honeycutt, J. D., Wyllie, D. H., Gilbert, S. C., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000490 · Cited by 160 · see citing works
Intervertebral disc degeneration—Current therapeutic options and challenges
Samanta, A., Lufkin, T., & Kraus, P. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1156749 · Cited by 162 · see citing works
Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting
Khare, R., Chen, C. Y., Weaver, E. A., & Barry, M. A. (2011) · Current Gene Therapy · doi:10.2174/156652311796150363 · Cited by 156 · see citing works
Successful Topical Respiratory Tract Immunization of Primates against Ebola Virus
Bukreyev, A. A., Rollin, P. E., Tate, M., Yang, L., Zaki, S. R., Shieh, W., Murphy, B. R., Collins, P. L., & Sanchez, A. (2007) · Journal of Virology · doi:10.1128/jvi.00105-07 · Cited by 155 · see citing works
Peste des Petits Ruminants Virus
Baron, M. D., Diallo, A., Lancelot, R., & Libeau, G. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.02.001 · Cited by 153 · see citing works
Novel viral vectors in infectious diseases
Humphreys, I. R., & Sebastian, S. (2017) · Immunology · doi:10.1111/imm.12829 · Cited by 148 · see citing works
Development of nonhuman adenoviruses as vaccine vectors
Bangari, D. S., & Mittal, S. K. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.101 · Cited by 142 · see citing works
Improved virus purification processes for vaccines and gene therapy
Nestola, P., Peixoto, C., Silva, R. J. S., Alves, P. M., Mota, J. P. B., & Carrondo, M. J. T. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25545 · Cited by 132 · see citing works
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Coughlan, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00909 · Cited by 132 · see citing works
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
Rijkers, G. T., Weterings, N., Obregón‐Henao, A., Dutt, T., Dutt, T. S., van Overveld, F. J., & Henao-Tamayo, M. I. (2021) · Vaccines · doi:10.3390/vaccines9080848 · Cited by 134 · see citing works
Adenovirus Vectors: Excellent Tools for Vaccine Development
Chang, J. (2021) · Immune Network · doi:10.4110/in.2021.21.e6 · Cited by 125 · see citing works
Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
Pelliccia, M., Andreozzi, P., Paulose, J., D’Alicarnasso, M., Cagno, V., Donalisio, M., Civra, A., Broeckel, R. M., Haese, N. N., Silva, P. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13520 · Cited by 123 · see citing works
Macropinocytotic Uptake and Infection of Human Epithelial Cells with Species B2 Adenovirus Type 35
Kälin, S., Amstutz, B., Gastaldelli, M., Wolfrum, N., Boucke, K., Havenga, M. J. E., DiGennaro, F., Liska, N., Hemmi, S., & Greber, U. F. (2010) · Journal of Virology · doi:10.1128/jvi.02494-09 · Cited by 126 · see citing works
Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
Price, G. E., Soboleski, M. R., Lo, C.-Y., Misplon, J. A., Quirion, M. R., Houser, K. V., Pearce, M. B., Pappas, C., Tumpey, T. M., & Epstein, S. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013162 · Cited by 121 · see citing works
Mucosal delivery of vaccine antigens and its advantages in pediatrics☆
DEMAGISTRIS, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.002 · Cited by 120 · see citing works
Hantavirus entry: Perspectives and recent advances
Mittler, E., Dieterle, M. E., Kleinfelter, L. M., Slough, M. M., Chandran, K., & Jangra, R. K. (2019) · Advances in virus research · doi:10.1016/bs.aivir.2019.07.002 · Cited by 121 · see citing works
Adenoviral vectors
Ghosh, S. S., Gopinath, P., & Ramesh, A. (2006) · Applied Biochemistry and Biotechnology · doi:10.1385/abab:133:1:9 · Cited by 118 · see citing works
Emerging viruses and current strategies for vaccine intervention
Afrough, B., Dowall, S., & Hewson, R. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13295 · Cited by 116 · see citing works
Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
Xing, Z., McFarland, C. T., Sallenave, J., Izzo, A. A., Wang, J., & McMurray, D. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005856 · Cited by 114 · see citing works
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Montero, C. G., Fraile‐Μartinez, O., Bravo, C., Torres‐Carranza, D., Sánchez‐Trujillo, L., Gomez-Lahoz, A. M., Guijarro, L. G., García‐Honduvilla, N., Asúnsolo, Á., Buján, J., et al. (2021) · Vaccines · doi:10.3390/vaccines9050433 · Cited by 109 · see citing works
Adenoviral vector-based strategies against infectious disease and cancer
Zhang, C., & Zhou, D. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1165908 · Cited by 110 · see citing works
Tuberculosis vaccines in clinical trials
Rowland, R., & McShane, H. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.28 · Cited by 110 · see citing works
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
Afkhami, S., Yao, Y., & Xing, Z. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.30 · Cited by 108 · see citing works
Adenovirus Structure
Rux, J. J., & Burnett, R. M. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1167 · Cited by 106 · see citing works
The Immunogenicity of Adenovirus Vectors Limits the Multispecificity of CD8 T-cell Responses to Vector-encoded Transgenic Antigens
Schirmbeck, R., Reimann, J., Kochanek, S., & Kreppel, F. (2008) · Molecular Therapy · doi:10.1038/mt.2008.141 · Cited by 105 · see citing works
Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity toPlasmodium falciparumCS Compared to That with Either Malaria Vaccine Alone
Stewart, V. A., McGrath, S. M., Dubois, P. M., Pau, M. G., Mettens, P., Shott, J. P., Cobb, M., Burge, J. R., LARSON, D. L., Ware, L. A., et al. (2007) · Infection and Immunity · doi:10.1128/iai.01879-06 · Cited by 103 · see citing works
Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9‐dependent maturation and IFN‐α production
Basner‐Tschakarjan, E., Gaffal, E., O’Keeffe, M. A., Tormo, D., Limmer, A., Wagner, H., Hochrein, H., & Tüting, T. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.964 · Cited by 102 · see citing works
Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods.
Mashel, T., Tarakanchikova, Y., Muslimov, A., Zyuzin, M., Timin, A., Lepik, K., & Fehse, B. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120282 · Cited by 92 · see citing works
Nanocarrier vaccines for SARS-CoV-2
Machhi, J., Shahjin, F., Das, S., Patel, M., Abdelmoaty, M. M., Cohen, J. D., Singh, P., Baldi, A., Bajwa, N., Kumar, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.002 · Cited by 80 · see citing works
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Pushparajah, D., Jimenez, S., Wong, S. L., Alattas, H., Nafissi, N., & Slavcev, R. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.003 · Cited by 98 · see citing works
Fully Detargeted Polyethylene Glycol-coated Adenovirus Vectors Are Potent Genetic Vaccines and Escape from Pre-existing Anti-adenovirus Antibodies
Wortmann, A., Vöhringer, S., Engler, T., Corjon, S., Schirmbeck, R., Reimann, J., Kochanek, S., & Kreppel, F. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300306 · Cited by 97 · see citing works
Gene therapy for haemophilia
Murphy, S. L., & High, K. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06942.x · Cited by 57 · see citing works
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
Ahmadi, S. E., Soleymani, M., Shahriyary, F., Amirzargar, M. R., Mahya, O., Fattahi, D., & Safa, M. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00597-z · Cited by 95 · see citing works
Chimpanzee-origin adenovirus vectors as vaccine carriers
Tatsis, N., Tesema, L., Robinson, E., Giles‐Davis, W., McCoy, K., Gao, G., Wilson, J. M., & Ertl, H. C. J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302675 · Cited by 93 · see citing works
Self-citation
Novel Vaccines to Human Rabies
Ertl, H. C. J. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000515 · Cited by 93 · see citing works
Self-citation
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Morse, M. A., Chaudhry, A., Gabitzsch, E. S., Hobeika, A. C., Osada, T., Clay, T. M., Amalfitano, A., Burnett, B. K., Devi, G. R., Hsu, D. S., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1400-3 · Cited by 93 · see citing works
The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity
Yang, T.-C., Millar, J., Groves, T., Grinshtein, N., Parsons, R., Takenaka, S., Wan, Y., & Bramson, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.200 · Cited by 92 · see citing works
Zika vaccines and therapeutics: landscape analysis and challenges ahead
Wilder‐Smith, A., Vannice, K., Durbin, A. P., Hombach, J., Thomas, S. J., Thevarjan, I., & Simmons, C. P. (2018) · BMC Medicine · doi:10.1186/s12916-018-1067-x · Cited by 90 · see citing works
Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Reyes‐Sandoval, A., Sridhar, S., Berthoud, T. K., Moore, A., Harty, J. T., Gilbert, S. C., Gao, G., Ertl, H. C. J., Wilson, J. M., & Hill, A. V. S. (2008) · European Journal of Immunology · doi:10.1002/eji.200737672 · Cited by 90 · see citing works
Self-citation
Long-Term Protective Immunity Induced Against Trypanosoma cruzi Infection After Vaccination with Recombinant Adenoviruses Encoding Amastigote Surface Protein-2 and Trans- Sialidase
Machado, A. V., Cardoso, J. E., Claser, C., Rodrigues, M. M., Gazzinelli, R. T., & Bruña–Romero, O. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.898 · Cited by 90 · see citing works
Evading the immune response upon in vivo gene therapy with viral vectors.
Sack, B. K., & Herzog, R. W. (2009) · PubMed · Cited by 89 · see citing works
Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine
Lokhandwala, S., Waghela, S. D., Bray, J., Sangewar, N., Charendoff, C. I., Martin, C. L., Hassan, W. S., Koynarski, T., Gabbert, L. R., Burrage, T. G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177007 · Cited by 89 · see citing works
Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
Penaloza‐MacMaster, P., Provine, N. M., Ra, J., Borducchi, E. N., McNally, A. G., Simmons, N. L., Iampietro, M. J., & Barouch, D. H. (2012) · Journal of Virology · doi:10.1128/jvi.02058-12 · Cited by 83 · see citing works
Review of COVID-19 viral vector-based vaccines and COVID-19 variants
Vanaparthy, R., Mohan, G., Vasireddy, D., & Atluri, P. (2021) · Infezioni in Medicina · doi:10.53854/liim-2903-3 · Cited by 88 · see citing works
A Critical Role for Type I IFN–dependent NK Cell Activation in Innate Immune Elimination of Adenoviral Vectors In Vivo
Zhu, J., Huang, X., & Yang, Y. (2008) · Molecular Therapy · doi:10.1038/mt.2008.88 · Cited by 88 · see citing works
Replication-Deficient Ebolavirus as a Vaccine Candidate
Halfmann, P., Ebihara, H., Marzi, A., Hatta, Y., Watanabe, S., Suresh, M., Neumann, G., Feldmann, H., & Kawaoka, Y. (2009) · Journal of Virology · doi:10.1128/jvi.00074-09 · Cited by 87 · see citing works
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques
Capone, S., Meola, A., Ercole, B. B., Vitelli, A., Pezzanera, M., Ruggeri, L., Davies, M. E. M., Tafi, R., Santini, C., Luzzago, A., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1688-1699.2006 · Cited by 87 · see citing works
Gene Therapy for Regenerative Medicine
Hosseinkhani, H., Domb, A. J., Sharifzadeh, G., & Nahum, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030856 · Cited by 88 · see citing works
A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
Khandker, S. S., Godman, B., Jawad, M. I., Meghla, B. A., Tisha, T. A., Khondoker, M. U., Haq, M. A., Charan, J., Talukder, A. A., Azmuda, N., et al. (2021) · Vaccines · doi:10.3390/vaccines9121387 · Cited by 84 · see citing works
Adenovirus Vectors Expressing Hantavirus Proteins Protect Hamsters against Lethal Challenge with Andes Virus
Safronetz, D., Hegde, N. R., Ebihara, H., Denton, M. C., Kobinger, G., Jeor, S. S., Feldmann, H., & Johnson, D. C. (2009) · Journal of Virology · doi:10.1128/jvi.00373-09 · Cited by 83 · see citing works
Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells
Cheng, C., Gall, J. G. D., Kong, W., Sheets, R., Gomez, P. L., King, C. R., & Nabel, G. J. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030025 · Cited by 83 · see citing works
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Rahimi, H., Salehiabar, M., Charmi, J., Barsbay, M., Ghaffarlou, M., Razlighi, M. R., Davaran, S., Khalilov, R. I., Sugiyama, M., Nosrati, H., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100895 · Cited by 83 · see citing works
Seroprevalence of neutralizing antibodies to human adenoviruses type‐5 and type‐26 and chimpanzee adenovirus type‐68 in healthy Chinese adults
Zhang, S., Huang, W., Zhou, X., Zhao, Q., Wang, Q., & Jia, B. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23546 · Cited by 82 · see citing works
Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions
Delplace, V., Payne, S. L., & Shoichet, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.065 · Cited by 81 · see citing works
COVID-19 Vaccines: An Overview of Different Platforms
Kudlay, D. A., & Svistunov, A. А. (2022) · Bioengineering · doi:10.3390/bioengineering9020072 · Cited by 79 · see citing works
Current view on novel vaccine technologies to combat human infectious diseases
Matić, Z., & Šantak, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11713-0 · Cited by 80 · see citing works
Recombinant covalently closed circular DNA of hepatitis B virus induces long‐term viral persistence with chronic hepatitis in a mouse model
Li, G.-Y., Zhu, Y.-F., Shao, D., Chang, H., Zhang, X., Zhou, D., Gao, Y.-Q., Lan, K., & Deng, Q. (2018) · Hepatology · doi:10.1002/hep.29406 · Cited by 71 · see citing works
Advances in Oral Subunit Vaccine Design
der Weken, H. V., Cox, E., & Devriendt, B. (2020) · Vaccines · doi:10.3390/vaccines9010001 · Cited by 78 · see citing works
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
Hensley, S. E., Cun, A. S., Giles-Davis, W., Li, Y., Xiang, Z., Lasaro, M. O., Williams, B. R. G., Silverman, R. H., & Ertl, H. C. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300024 · Cited by 78 · see citing works
Self-citation
Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus
Singh, N., Pandey, A., Jayashankar, L., & Mittal, S. K. (2008) · Molecular Therapy · doi:10.1038/mt.2008.12 · Cited by 78 · see citing works
Dengue Virus Vaccine Development
Yauch, L. E., & Shresta, S. (2014) · Advances in virus research · doi:10.1016/b978-0-12-800098-4.00007-6 · Cited by 77 · see citing works
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys
Ersching, J., Hernández, M. I. M., Cezarotto, F. S., Ferreira, J. D. S., Martins, A. B., Switzer, W. M., Xiang, Z., Ertl, H. C. J., Zanetti, C. R., & Pinto, A. R. (2010) · Virology · doi:10.1016/j.virol.2010.07.043 · Cited by 76 · see citing works
Self-citation
Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens
Lokhandwala, S., Waghela, S. D., Bray, J., Martin, C. L., Sangewar, N., Charendoff, C. I., Shetti, R., Ashley, C., Chen, C.-H., Berghman, L. R., et al. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00395-16 · Cited by 76 · see citing works
iTRAQ-Based and Label-Free Proteomics Approaches for Studies of Human Adenovirus Infections
Trinh, H. V., Grossmann, J., Gehrig, P., Roschitzki, B., Schlapbach, R., Greber, U. F., & Hemmi, S. (2013) · International Journal of Proteomics · doi:10.1155/2013/581862 · Cited by 72 · see citing works
Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors
Hensley, S. E., Giles‐Davis, W., McCoy, K. C., Weninger, W., & Ertl, H. C. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6032 · Cited by 73 · see citing works
Self-citation
Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles
Srivastava, A. K., Gowda, D. V., Madhunapantula, S. V., Shinde, C. G., & Meenakshi, S. S. (2015) · Apmis · doi:10.1111/apm.12351 · Cited by 72 · see citing works
Vaccination strategies against Zika virus
Fernández, E., & Diamond, M. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.03.006 · Cited by 72 · see citing works
Vaccination against tuberculosis: How can we better BCG?
Pitt, J. M., Blankley, S., McShane, H., & O’Garra, A. (2012) · Microbial Pathogenesis · doi:10.1016/j.micpath.2012.12.002 · Cited by 71 · see citing works
Evaluation of OX40 Ligand as a Costimulator of Human Antiviral Memory CD8 T Cell Responses: Comparison with B7.1 and 4-1BBL
Serghides, L., Bukczynski, J., Wen, T., Wang, C., Routy, J., Boulassel, M., Sékaly, R., Ostrowski, M., Bernard, N. F., & Watts, T. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6368 · Cited by 72 · see citing works
Comparison of Vaccine-Induced Effector CD8 T Cell Responses Directed against Self- and Non–Self-Tumor Antigens: Implications for Cancer Immunotherapy
Pedersen, S. R., Sørensen, M. R., Buus, S., Christensen, J. P., & Thomsen, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300555 · Cited by 72 · see citing works
Development of replication-competent viral vectors for HIV vaccine delivery
Parks, C. L., Picker, L. J., & King, C. R. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328363d389 · Cited by 71 · see citing works
Oral Vaccines: A Better Future of Immunization
Kwong, K. W.-Y., Xin, Y., Lai, N. C.-Y., Sung, J. C.-C., Wu, K.-C., Hamied, Y. K., Sze, E. T.-P., & Lam, D. M. (2023) · Vaccines · doi:10.3390/vaccines11071232 · Cited by 74 · see citing works
Antigen delivery systems for veterinary vaccine development
Brun, A., Albina, E., Barret, T., Chapman, D. A., Czub, M., Dixon, L. K., Keil, G. M., Klonjkowski, B., Potier, M. L., Libeau, G., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.044 · Cited by 71 · see citing works

Authors: Tatsis, N., & Ertl, H. C. J.
Affiliations: The Wistar Institute (US)
Corresponding author: Ertl, Hildegund C.J.
ORCID: Ertl, Hildegund C.J.
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2004-10
Volume: 10
Issue: 4
Pages: 616-629
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1016/j.ymthe.2004.07.013
PMC: PMC7106330
OpenAlex: W1972258033
Cited by: 669
References: 134
Citations by year: 2026: 16 · 2025: 28 · 2024: 31 · 2023: 60 · 2022: 58 · 2021: 69 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 24 · 2014: 21 · 2013: 28 · 2012: 23
FWCI: 3.15
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4389 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: adenoviral vector, vaccine vectors, subunit vaccine, viral vaccines, innate immune response, adaptive immune response, transgene expression, HIV-1 vaccine, malaria vaccine, tumor-associated antigens
MeSH terms: Adenoviridae, Adenoviridae Infections, Genes, Viral, Genetic Vectors, Humans, Peptides, Viral Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adenoviruses as vaccine vectors

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks